1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA FERMT1 CTRPv2 pan-cancer AAC 0.2 9e-07
mRNA PIWIL4 CTRPv2 pan-cancer AAC 0.18 9e-07
mRNA C1QC CTRPv2 pan-cancer AAC 0.17 9e-07
mRNA KCNN4 CTRPv2 pan-cancer AAC 0.18 9e-07
mRNA EPS8L3 CTRPv2 pan-cancer AAC 0.21 9e-07
mRNA TFE3 CTRPv2 pan-cancer AAC -0.19 1e-06
mRNA SOX10 CTRPv2 pan-cancer AAC 0.27 1e-06
mRNA RAB23 CTRPv2 pan-cancer AAC -0.19 1e-06
mRNA MYO1F CTRPv2 pan-cancer AAC 0.19 1e-06
mRNA ATP1A1 CTRPv2 pan-cancer AAC 0.19 1e-06
Download CSV